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A Powerful Strategy to Account for Multiple Testing in the Context of
Haplotype Analysis
Tim Becker and Michael Knapp
Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn
Haplotypes—that is, linear arrangements of alleles on the same chromosome that were inherited as a unit—are
expected to carry important information in the context of association ﬁne mapping of complex diseases. In con-
sideration of a set of tightly linked markers, there is an enormous number of different marker combinations that
can be analyzed. Therefore, a severe multiple-testing problem is introduced. One method to deal with this problem
is Bonferroni correction by the number of combinations that are considered. Bonferroni correction is appropriate
for independent tests but will result in a loss of power in the presence of linkage disequilibrium in the region. A
second method is to perform simulations. It is unfortunate that most methods of haplotype analysis already require
simulations to obtain an uncorrected P value for a speciﬁc marker combination. Thus, it seems that nested sim-
ulations are necessary to obtain P values that are corrected for multiple testing, which, apparently, limits the
applicability of this approach because of computer running-time restrictions. Here, an algorithm is described that
avoids such nested simulations. We check the validity of our approach under two disease models for haplotype
analysis of family data. The true type I error rate of our algorithm corresponds to the nominal signiﬁcance level.
Furthermore, we observe a strong gain in power with our method to obtain the global P value, compared with
the Bonferroni procedure to calculate the global P value. The method described here has been implemented in the
latest update of our program FAMHAP.
Introduction
Data on densely spaced markers within one gene or hap-
lotype block have become a reality. Although the use-
fulness of haplotype analysis in such a situation is com-
monly accepted, there is still no consensus on how the
analysis should be performed. Multiple testing is an im-
portant problem in this context. With n markers, there
are marker combinations for which a haplotype-n2  1
based test can be performed. Hence, for 20 markers,
1,000,000 tests are possible, and it is clear that hardly
any P value will withstand a Bonferroni correction by
that number. A common approach to reducing the num-
ber of tests is to use a sliding window—that is, to test
only combinations with a ﬁxed number of neighboring
markers. However, the size of such windows has to be
chosen in advance, which leads to an important loss of
ﬂexibility when haplotypes of interest are shorter than
or extend over the chosen window size. Furthermore,
cis-acting effects on the disease of markers that are not
neighbors are always missed. Finally, correction is still
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needed for the number of windows and for the number
of markers that are analyzed as single loci.
Here, we describe a method that allows for the anal-
ysis of all marker combinations or a set of prespeciﬁed
marker combinations—for example, all marker com-
binations with k markers. Suppose that, for each
marker combination, we have one test the underlying
statistic of which depends on the haplotype distribution
with respect to these markers. We consider the global
null hypothesis—that none of the marker combinations
shows association with the disease. It is then natural to
try to assess the global signiﬁcance with the statistic
, which is the maximum of the statistics over allTmax
marker combinations. Since the distribution of isTmax
generally unknown, P values are obtained through
Monte Carlo simulations. The approach has beenTmax
used, for instance, by McIntyre et al. (2000) for the
single-locus analysis of several markers by use of the
transmission/disequilibrium test (TDT) by Spielman et
al. (1993). In our situation, however, a maximum sta-
tistic will not sufﬁce, since the test statistics for com-
binations with different numbers of markers are usually
not comparable. Therefore, we replace with ,minT Pmax
the smallest raw P value found among the combina-
tions. Since the distribution of is not known, sig-minP
niﬁcance has to be assessed with Monte Carlo simula-
tions. This approach was considered, for instance, by
Lazzeroni and Lange (1998) and by Jannot et al. (2003).
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Although the null distribution of the test statistic for a
single hypothesis is known in situations described by
Lazzeroni and Lange (1998) and by Jannot et al. (2003),
in the context of haplotype analysis, even these null
distributions are often unknown. For example, a
method to perform a haplotype-based TDT-like test for
samples of families with a single affected child has been
given by Zhao et al. (2000) and has been extended to
general nuclear families by Knapp and Becker (2003).
A transmission/nontransmission table for haplotypes is
constructed, in which the possible transmission patterns
of each family are weighted with a relative likelihood
based on estimated haplotype frequencies. The distri-
bution of the corresponding test statistic under the null
hypothesis is unknown, and the raw P value has to be
obtained through permutation replicates, in which the
transmission/nontransmission status of the haplotypes
is randomly permuted. Therefore, a nested simulation
strategy seems to be necessary to obtain the distribution
of , since, in each of the permutation replicates, theminP
raw P value for each marker combination is needed and
has to be obtained through permutation replicates. This
will often be computationally unfeasible.
Although the raw P value for each test has to be
obtained through permutation replicates, it is possible
to assess the overall signiﬁcance for all marker com-
binations without nested simulations. Ge et al. (2003)
have shown that a single set of permutations is sufﬁcient
to obtain raw P values for each marker combination
and to estimate the distribution of . They appliedminP
this idea to a multiple-testing problem that occurs with
microarray data. We provide an adaption of their idea,
taking into account sample size, running time, and com-
puter-storage requirements that differ between micro-
array and haplotype data. We check the validity and
power of our approach with a simulation study under
two disease models. Finally, we demonstrate its appli-
cability by reanalyzing a recently published association
study.
Methods
Association Testing Using Multiple Tightly Linked
Markers
Consider n tightly linked markers, and let A p
. Any nonempty subset B of A is called a{1,… , n}
“marker combination.” Zhao et al. (2000) proposed a
TDT-like association test for the hypothesis —thatBH0
there is no disease association with marker combination
B—which can be applied to samples consisting of nu-
clear families with a single affected child. Their approach
was subsequently extended to samples of nuclear fam-
ilies with an arbitrary number of children (Knapp and
Becker 2003). In brief, this test proceeds with the fol-
lowing steps.
1. The maximum-likelihood frequency estimates for
each haplotype of marker combination B are
computed.
2. In the case that the observed single-marker geno-
types of a family allow for more than one haplotype
explanation, the frequency estimates of step 1 are
used to calculate weights (which sum to 1 within
a family) for each of these possible haplotype
explanations.
3. With ambiguous families replaced by a set of
weighted haplotype explanations, the test statistic
of any extension of the TDT for a single-marker
locus with 12 alleles can be used to calculate the
value for the observed data. Here, we considerBT0
the statistic proposed by Spielman and Ewens
(1996), which requires calculation of a table of
transmitted/nontransmitted haplotypes. Each af-
fected child contributes 2 units to this table. Only
families with complete genotype information for
all loci of marker combination B contribute to this
table.
4. The P value is assessed by simulation. In eachBP0
replicate of this simulation, a sample is constructed
in which all marker genotypes of all children are
either left unchanged or replaced by the two non-
transmitted parental alleles, with equal chance.
Since only fully genotyped families are used, this is
equivalent to changing the transmission/nontrans-
mission status of each possible haplotype expla-
nation of a family. Let denote the value of theBTi
test statistic obtained for the ith replicate. Then,
is the fraction of permutation replicates resultingBP0
in a test statistic greater than or equal to the test
statistic of the real data; that is,
B Bd {i:T  T } di 0BP p ,0 t
where t denotes the number of permutation repli-
cates and denotes the number of el-B BF{i:T  T }Fi 0
ements of a set A.
Testing More Than One Hypothesis
Now suppose that not only a single marker combi-
nation B should be tested for its association with the
disease, but that a set of marker combinations shouldB
be evaluated. Let be the global null hy-BH pW H0 BB 0
pothesis—that none of the marker combinations B 
is associated with the disease. Our central goal is toB
construct a test for this global hypothesis. The preceding
section described a method to obtain for each hy-BP0
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Table 1
Hypothetical Example for Three Tightly Linked Markers and 10 Permutation Replicates
DATA
VALUES FOR MARKER COMBINATION B p
minP
{1} {2} {3} {1,2} {1,3} {2,3} {1,2,3}
BTi
BPi
BTi
BPi
BTi
BPi
BTi
BPi
BTi
BPi
BTi
BPi
BTi
BPi
Real data 3.00 .20 2.12 .20 2.00 .40 4.48 .10 2.44 .30 3.03 .20 6.47 .20 .10
Replicate:
1 2.01 .40 .01 1.00 2.02 .30 1.42 .50 .00 1.00 3.01 .40 4.47 .40 .30
2 3.12 .00 4.12 .00 2.12 .20 5.44 .00 .44 .50 7.33 .00 9.47 .00 .00
3 2.99 .30 3.12 .10 3.22 .00 1.44 .30 4.44 .10 3.02 .30 8.47 .10 .00
4 3.02 .10 1.02 .50 2.22 .10 1.43 .40 5.44 .00 6.33 .10 5.47 .30 .00
5 1.44 .50 1.12 .30 1.99 .50 1.41 .60 .03 .90 3.00 .50 .02 1.00 .30
6 .99 .60 1.11 .40 .74 1.00 1.40 .70 .04 .80 2.99 .60 .37 .90 .40
7 .78 .70 .12 .60 .75 .90 4.44 .20 .34 .60 2.87 .70 .47 .80 .20
8 .13 1.00 .11 .70 1.00 .80 1.34 .80 1.44 .40 2.84 .80 1.47 .70 .40
9 .55 .80 .02 .90 1.88 .60 .44 1.00 3.44 .20 1.33 .90 2.47 .60 .20
10 .42 .90 .10 .80 1.07 .70 1.24 .90 .24 .70 1.04 1.00 3.47 .50 .50
pothesis . is called “raw P value” or “unadjustedB BH P0 0
P value” for hypothesis . It seems intuitively reason-BH0
able that the testing procedure for the global hypothesis
should depend on ; that is, themin BH P p min P0 BB 0
global null hypothesis is rejected in the case that the
minimum of the raw P values is sufﬁciently small. Thus,
it is necessary to determine the distribution of inminP
the case that holds true. Again, this can be achievedH0
by simulation. Since, in each replication of this simu-
lation, it is necessary to obtain the P value for each B
(which requires simulations itself), nested simulations
seem to be necessary. The obvious drawback of such
nested simulations is running time. However, we show
here how these nested simulations can be avoided.
The basic idea is to use the same set of permutation
replicates to determine the empirical distribution of
that has been used to determine . For each hy-min BP P0
pothesis and for each permutation replicateB  B i p
, the uncorrected P value of the ith permutation1,… , t
replicate is calculated as
B BF{s:0  s  t, s ( i, T  T }Fs iBP p . (1)i t
(Note that the real data serves as a “permutation rep-
licate” for the calculation of .) For , letB minP i 1 0 P pi i
be the minimum of the uncorrected P valuesBmin PBB i
for all marker combinations in the ith permutation rep-
licate. Then, the P value for the global hypothesis isH0
calculated as
min minF{s:1  s  t, P  P }FiP p . (2)
t
Table 1 provides an example that explains the strategy.
(Of course, 110 permutation replicates are needed in
practice.) For the real data, the smallest raw P value is
obtained for marker combination , so thatB p {1,2}
. We observe a smaller for the permu-min minP p .10 Pi
tation replicates . Thus, the P value for thei  {2,3,4}
global hypothesis is estimated to be .30.H0
The idea to calculate the raw P values ( ) and theBP0
empirical distribution of from a single set of per-minP
mutation replicates is the basis of a method, recently
proposed by Ge et al. (2003), for obtaining so-called
minP-adjusted P values (Westfall and Young 1993).
Therefore, the following section summarizes the algo-
rithm of Ge et al. (2003), and the subsequent section
describes the details and modiﬁcations of our adaption
of this basic idea for testing the global null hypothesis.
Algorithm for Step-Down minP-Adjusted P Values, by
Ge et al. (2003)
First, it should be noted that the goal of Ge et al.
(2003) is slightly different from our goal to construct a
test for the global null hypothesis . Their algorithmH0
aims to obtain so-called minP-adjusted P values forB˜P0
each hypothesis . If the global null hypothesisBH H0 0
holds true, the probability is a that one or more of
these adjusted P values is a. Therefore, it is evident
that the rule “reject in the case that the smallest ofH0
the adjusted P values is a” deﬁnes a level-a test for
. Since the smallest adjusted P value belongs to theH0
same hypothesis for which the unadjusted P value is
smallest, for the purpose of testing , it would be suf-H0
ﬁcient to calculate only the adjusted P value for the
hypothesis that possesses the smallest unadjusted P
value, instead of calculating all adjusted P values ,B˜P0
. The initial step of the algorithm of Ge et al.B  B
(2003, cf. step 0 in box 4 on p. 21) requires obtaining
raw P values for each hypothesis. However, this require-
ment is a direct consequence of their goal to obtain B˜P0
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for all , and it can be dropped in the case thatB  B
only the adjusted P value for the hypothesis with the
smallest unadjusted P value has to be calculated.
Second, a minor technical difference between the al-
gorithm of Ge et al. (2003) and our approach is that
these authors use
B BF{s:1  s  t, T  T }Fs iBP p (3)i t
instead of (1) for calculation of uncorrected P values of
the ith permutation replicate. Recently, there has been
debate on how to estimate P values by Monte Carlo
methods. North et al. (2002, 2003) prefer the estimate
, where n is the number of permutation(r 1)/(n 1)
replicates and r is the number of these replicates that
produce a test statistic greater than or equal to that
calculated for the actual data. Broman and Caffo (2003)
and Ewens (2003) favor the traditional estimate .r/n
Now, Ge et al. (2003) employ this traditional estimate
in obtaining the raw P values , whereas their appli-BP0
cation of equation (3) in obtaining raw P values of the
ith permutation replicate makes use of the proposal by
North et al. (2002, 2003). We agree with Broman and
Caffo (2003) that neither nor shouldr/n (n 1)/(r 1)
be considered incorrect, but we believe that it is reason-
able to use the same approach for both purposes—that
is, calculation of raw P values for the real data and for
the permutation replicates. Therefore, we employ equa-
tion (1) instead of equation (3). Note that, in the case
that all possible permutation replicates are evaluated in
obtaining , equation (3) is appropriate. Indeed, whenBPi
all replicates can be conducted, there is one replicate
that is identical to the real data. Hence, it is reasonable
to compare a replicate to itself, since the real data is
compared to itself as well. In contrast to the microarray
problem considered by Ge et al. (2003), the set of all
permutation replicates is always much too large for our
problem of haplotype-association testing.
The main merit of the algorithm by Ge et al. (2003)
is that it does not require storage of the whole table
of test statistics per hypothesisBT (i p 1,… , t ; B  B )i
B and permutation replicate i, but only requires storage
of the test statistics for a single hypothesis at a time. The
algorithm is presented in the context of microarray data,
for which the number of hypotheses (i.e., the number of
genes for which expression is measured) is usually large
compared with the number of individuals considered
(typically ! 20). For haplotype data, the number of
marker combinations tested is low for !10 SNPs and
can reasonably be limited by consideration of only
marker combinations with !4 or 5 markers when more
SNPs are typed. Here, a computer memory problem oc-
curs when many permutation replications have to be
conducted (e.g., in the case that very small global P
values have to be estimated), whereas, for microarray
data, even the number of all possible permutations of
the real data (i.e., permutations of the disease status of
the individuals) is small, because the total number of
individuals is very small. Therefore, we have imple-
mented an approach to solve the computer memory
problem that is more appropriate for haplotype data.
Algorithm for Testing the Global Null Hypothesis H0
The algorithm for testing the global null hypothesis—
that none of the marker combinations is associ-B  B
ated with the disease—has been implemented in the pro-
gram FAMHAP (Becker and Knapp 2004), which orig-
inally was developed to obtain maximum-likelihood
estimates of haplotype frequencies from samples con-
sisting of arbitrary nuclear families. Two options are
provided for describing the set ofmarker combinationsB
B: (1) with option ”maxmarker p k,” only marker com-
binations B consisting of loci are considered; k (k  n)
(2) with option “window p yes,” only marker combi-
nations of neighboring markers are considered. With a
deﬁned , the program proceeds with the followingB
steps.
1. Estimate frequencies for the full n-locus haplotypes
from the data. For each marker combination B 
, obtain frequencies for each haplotype of B byB
summing all corresponding n-locus haplotype fre-
quencies. Calculate and store the table of trans-
mitted/nontransmitted haplotypes (cf. step 3 in as-
sociation test) for each and for each familyB  B
with complete marker genotypes at all marker loci
of B.
2. For all B, compute the test statistic .BT0
3. For each family, randomly transpose (cf. step 4 in
association test) the table of transmitted/nontrans-
mitted haplotypes (cf. step 1) for all . Re-B  B
compute and store for these modiﬁed data.BTi
4. Repeat step 3 t times.
5. Calculate by use of equations (1) andB minP P pi i
.Bmin PBB i
6. Calculate the P value for the global hypothesis
by use of equation (2).H0
The memory requirement to store for each permu-BTi
tation replicate and for each marker com-i p 1,… , t
bination is of the order . With 1,000B  B dB d # t
marker combinations and 100,000 permutation repli-
cates, test statistics have to be stored, and it is ob-810
vious that the number of permutation replicates cannot
be increased much further. However, a huge number of
permutation replicates is needed only for estimating
small global P values or for performing the test of the
global null hypothesis at small type I error rate (North
et al. 2002). For this, the program provides the option
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Table 2
Haplotype Distribution
CORE HAPLOTYPE
LD BETWEEN CORE HAPLOTYPE
AND NEIGHBORING SNP
Lefta Rightb
111 .30 .30
112 .30 .30
121 .30 .30
211 .60 .60
222 .65 .65
a Probability that the SNP to the left of the core block
carries allele 1, given the core haplotype.
b Probability that the SNP to the right of the core
block carries allele 1, given the core haplotype.
“alpha p !value1,” which enforces the condition that
only the !value1 # t permutation replicates with the
highest test statistics are stored for each marker com-
bination. This information is sufﬁcient to decide if the
P value corresponding to the global null hypothesis is
value. Indeed, in the case that does not
 B BP 1 a Ti i
belong to the !value1 # t permutation replicates with
the highest test statistic for marker combination .B
It follows that (i.e., the concretemin BP p min Pi BB '{B } i
value of is irrelevant for calculating ), or
B minP Pi i
(i.e., even the concrete value of is irrelevantmin minP 1 a Pi i
for deciding whether the global P value is a). With
option “alpha p !value1,” the storage requirement is
reduced to !value1 # # t. Typically, !value1 #dB d
is !1 in situations in which the number of per-dB d
mutation replicates is too large to allow storage of the
whole table of test statistics.
Because of the discreteness of the distribution of
, generally some of the permutation replicates willminP
give . In accordance with equation (2), all ofmin minP p Pi
these permutation replicates have to be counted for de-
termination of the global P value for . As an example,H0
suppose that, in table 1, permutation replicate 2 was the
real data and the real data were one of the permutation
replicates, with . Since for permu-min minP p .0 P p .0i
tation replicates 3 and 4 as well, the global P value is
.2, as calculated by equation (2). Now, it is reasonable
to enforce an order for data sets with identical smallest
raw P value by consideration of the second smallest raw
P value, which will be denoted for the real datamin2P
and for permutation replicate i. Then, the P valuemin2Pi
for the global null hypothesis can be calculated by use
of
min minP p F{1  s  t:P ! P ori
min min min2 min2(P p P and P  P )}F/t (4)i i
instead of equation (2). For the example of table 1 (and
under the assumption that permutation replicate 2 was
the real data), raw P values are .0 for two further mark-
er combinations (i.e., ), whereas the secondmin2P p .0
smallest raw P values for permutation replicates 3 and
4 are .1. Calculated by use of equation (4), the global
P is .0 instead of .2. Of course, it is possible that the
second smallest P values of two permutation replicates
are identical as well and that it would be necessary to
consider the third smallest P values, and so on. However,
the number of such instances (which is printed out by
our program) will be small in practice, and our imple-
mentation takes into account only the improvement that
can be obtained from the consideration of the second
smallest raw P value.
Note that there is a potential conﬂict in using equation
(4) instead of equation (2) with the option “alpha p
!value1.” If the second smallest raw P value for the real
data is 1 value, this value will not have been stored, and
the global P value has to be determined by use of equa-
tion (2). However, if value, the improved deter-min2P 
mination of the global P value can be applied even in
combination with option “alpha p !value1.” In addi-
tion, the discreteness of the distribution of is mostminP
pronounced in the case that the number of permutation
replicates is relatively small, whereas, for a large number
of permutation replicates, the difference between equa-
tion (2) and equation (4) will be less important. On the
other hand, the option “alpha p !value1” is not re-
quired if the number of permutation replicates is small.
Simulations
We performed a simulation study for samples of 233
trios and samples of 175 nuclear families with two af-
fected children. We tried to model the situation of many
markers within a small region with just ﬁve SNP mark-
ers. We simulated three core SNPs, which can be viewed
as tagging SNPs of a haplotype block, and one SNP on
both sides of the block, each of which was only in mod-
erate linkage disequilibrium (LD) with the core block.
These SNPs model the borders of the analyzed region.
The core region of the three SNPs comprised ﬁve hap-
lotypes. We simulated a diallelic disease locus under a
dominant and a recessive model, with a prespeciﬁed rel-
ative risk of 2 and an attributable fraction of 0.20. We
assumed a recombination fraction of zero between the
disease locus and the core block. The ﬁrst of the ﬁve
core haplotypes had the same frequency as the disease
allele and was assumed to be in in complete LD with
the disease allele. The other haplotypes at the core block
were chosen from a uniform distribution. We addition-
ally simulated a neighboring SNP on the left and on the
right of the core block, depending on the core haplotype.
The extent of the LD between each core haplotype and
the neighboring markers can be found in table 2. Under
all scenarios, we used 3,000 simulated data sets and
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Table 3
Empirical Signiﬁcance Level at a p 0.05
DATA STRUCTURE,
MAXMARKER,a
AND WINDOWb
NO. OF
COMBINATIONS
EMPIRICAL SIGNIFICANCE LEVEL UNDER MODEL
Recessive Dominant
Bestc Bonferronid Global Bestc Bonferronid Global
Trios:
1:
… 5 .192 .039 .051 .193 .024 .051
2:
Yes 9 .240 .031 .049 .239 .032 .054
No 15 .272 .026 .046 .279 .024 .052
3:
Yes 12 .249 .025 .052 .252 .024 .051
No 25 .301 .023 .047 .322 .020 .049
5:
Yes 15 .260 .024 .049 .268 .017 .050
No 31 .322 .022 .047 .331 .017 .053
Nuclear families:
1:
… 5 .161 .034 .046 .173 .038 .048
2:
Yes 9 .212 .027 .047 .217 .032 .048
No 15 .270 .025 .048 .272 .025 .048
3:
Yes 12 .239 .023 .044 .240 .027 .051
No 25 .325 .022 .047 .306 .021 .049
5:
Yes 15 .258 .022 .046 .261 .024 .049
No 31 .326 .019 .047 .319 .018 .050
a Maximum number of markers in combination B.
b When “window p yes,” only combinations of neighboring markers are tested.
c Uncorrected smallest P value.
d Bonferroni-corrected smallest P value.
computed the global P value with 4,000 permutation
replicates for each simulated data set. We also checked
the size of our test by simulations under the null hy-
pothesis. For this purpose, we enforced linkage equilib-
rium between the disease locus and the markers. Em-
pirical signiﬁcance levels and power were computed as
the portion of simulated data sets for which the global
P value or the Bonferroni-corrected smallest rawP value,
respectively, was .05.
Results
We have integrated our method into our program FAM-
HAP, which was developed for haplotype frequency es-
timation in nuclear families. In particular, haplotype fre-
quencies and lists of haplotype explanations that are
necessary for the computation of the underlying test sta-
tistic can be computed internally. Thus, time-consuming
communication between different software packages can
be avoided. The simulation study was performed on a
Pentium III PC with 512 megabytes of main memory.
The evaluation of a single data set with 4,000 permu-
tation replicates took 10 s, on average, to obtain the
raw P values for all 31 marker combinations and the
corresponding global P value. A total of 3,000 simulated
data sets had to be evaluated for each of 56 different
situations, since we conducted simulations under the
null hypothesis and the alternative, under two disease
models, for two different data structures and for seven
different conﬁgurations of “maxmarker” and “win-
dow.” In total, our simulation study ran for ∼ 56 #
that is, ∼19.5 d. With nested simulations,3,000 # 10 s,
permutation replicates would have been4,000 # 4,000
necessary to obtain the global P for a single simulated
data set. Thus, our simulation study with nested simu-
lations would have taken d, which is ∼2144,000 # 19.5
years and would not have been feasible.
In table 3, the empirical signiﬁcance levels for the
different data structures and disease models are shown.
(The disease model is relevant only for the haplotype
frequencies.) In addition, we varied the number of
marker combinations tested, by allowing only marker
combinations withk p 1, 2, 3, and 5 markers (“max-
marker p k”), or by allowing only combinations of
neighboring markers (“window p yes”). Under all
models and marker combinations, the true type I error
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Table 4
Empirical Power of Testing a Single Marker
Combination ( )a p 0.05
DATA STRUCTURE AND
SNP MARKERS TESTED
POWER UNDER MODEL
Recessive Dominant
Trios:
2 .399 .213
3 .407 .211
4 .420 .225
2,3 .571 .350
2,4 .569 .355
3,4 .586 .341
2,3,4 .735 .719
Nuclear families:
2 .618 .385
3 .609 .386
4 .612 .378
2,3 .818 .635
2,4 .825 .622
3,4 .805 .640
2,3,4 .934 .942
rate for the test that rejects in the case that theH0
smallest P value is .05 is markedly above .05. As ex-
pected, this effect becomes stronger as the number of
tested combinations increases. These high true type I
error rates show that even with a considerable amount
of LD, multiple testing is still an important problem.
On the other hand, Bonferroni correction leads to true
type I error rates that are too small, because it ignores
the LD of the region. Indeed, when many marker com-
binations are tested, the true level for the Bonferroni
correction is ∼0.02 rather than 0.05. With our global
P values, however, under none of the scenarios did we
observe a signiﬁcant deviation from the nominal level
. Thus, our method is a valid testing procedurea p 0.05
that adequately accounts both for the number of tests
and for the LD of a region. The nominal level is also
maintained with samples consisting of nuclear families
with two children, which conﬁrms that we obtain a
valid test for association from this family structure. Ta-
ble 4 shows the power of testing for the uncorrected P
values of the marker combinations of the core region,
whereas table 5 shows the results of the power studies
with Bonferroni correction and our global P values. In
accordance with the simulation setting, the power of
the uncorrected tests in table 4 is smallest for the single
markers, increases when 2-marker haplotypes are con-
sidered, and is best for the 3-marker combination, ir-
respective of the data structure or disease model. Table
5 shows that the power improvement of the haplotype
analysis is maintained even after the multiple testing is
taken into account. In general, the power under our
global P values is considerably higher than under Bon-
ferroni-corrected P values and lies about halfway be-
tween the power obtained by Bonferroni-corrected and
uncorrected P values of the best combination, which
represents the upper limit of what can be reached (for
instance, if one knew the best combination in advance
from an independent source). Both for Bonferroni-cor-
rected and for global P values, the power increases with
the number of considered markers and reaches its op-
timum when only combinations of 3 neighboring
markers are considered (“maxmarker p 3”; “window
p yes”). This is consistent with our simulation setup,
which modeled a 3-marker disease haplotype of neigh-
boring markers. However, whereas the power of the
Bonferroni correction drops when too many combina-
tions are tested (“maxmarker p 5”; “window p no”),
tests of too many combinations have only a slight im-
pact on the power when our global P values are com-
puted. This shows that our method is able to capture
the dependence of the tests and that it is not negatively
affected by the consideration of effects of a high order
or cis-acting effects if there are no such effects. Besides
the comparison of the Bonferroni-corrected and our
global P values, we consistently observe a higher power
for the nuclear families with two affected children than
for the trio sample, although the sample size for both
data structures is equal with respect to genotyping ef-
fort. The better power of data from nuclear families
with two affected children may partially be explained
by the fact that families with multiple affected siblings
are genetically more loaded and therefore lead to an
increased power (Risch and Teng 1998; Fingerlin et al.
2004).
Application to a Real Data Set
After an initial ﬁnding by Straub et al. (2002), Schwab
et al. (2003) have recently reported supportive evidence
for association of schizophrenia with multilocus hap-
lotypes in the 6p22.3 gene, dysbindin. They typed mark-
ers rs3213207 (SNP 1), rs1011313 (SNP 2), rs2619528
(SNP 3), rs760761 (SNP 4), rs2619522 (SNP 5), and
rs1018381 (SNP 6) in a sib-pair sample (78 families)
and in an independently ascertained trio sample (125
families). Schwab et al. (2003) reported the results of
association analyses performed with the methods of
Zhao et al. (2000) and Knapp and Becker (2003) for all
marker combinations of 5 markers and for the sib-
pair sample, the trio sample, and the combined sample.
The greatest evidence for association was found in the
combined sample (without six Israeli families) for the
combination of SNPs 2 and 4. However, with the soft-
ware that was used at that time, it was not possible to
conduct 1200,000 permutation replicates. None of these
replicates resulted in a test statistic greater than or equal
to the statistic of the real data for this marker combi-
nation. Schwab et al. (2003) concluded that the raw
was almost certainly smaller than for this{2,4} 5P 2 # 100
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Table 5
Empirical Power of Testing a Set of Marker Combinations ( ) for the Globala p 0.05
Hypothesis
DATA STRUCTURE,
MAXMARKER,
AND WINDOW
NO. OF
COMBINATIONS
EMPIRICAL POWER UNDER MODEL
Recessive Dominant
Bonferronia Global Bonferronia Global
Trios:
1:
… 5 .409 .441 .230 .250
2:
Yes 9 .469 .556 .277 .360
No 15 .432 .553 .264 .359
3:
Yes 12 .526 .601 .436 .524
No 25 .439 .580 .339 .479
5:
Yes 25 .499 .599 .422 .521
No 31 .437 .582 .352 .499
Nuclear Families
1:
… 5 .664 .729 .429 .497
2:
Yes 9 .753 .819 .556 .640
No 15 .743 .823 .559 .666
3:
Yes 12 .799 .862 .778 .837
No 25 .747 .843 .721 .808
5:
Yes 25 .779 .854 .773 .840
No 31 .728 .835 .714 .810
a The power of the procedure, which is based on Bonferroni-corrected smallest raw
P value.
2-marker combination and applied a Bonferroni correc-
tion. With our new implementation, we were able to
conduct permutation replicates, and we obtained a810
raw P value of for this marker com-{2,4} 6P p 2 # 100
bination. For very small P, the coefﬁcient of variation
(i.e., SD divided by the mean) of a raw P value estimated
by t permutation replicates is . Therefore,∼ 1/ t # P
permutation replicates are adequate to ensure8t p 10
that the coefﬁcient of variation of the raw P value is
∼10% in the case that the true raw P value for a speciﬁc
marker combination is ∼106. Our program (with option
“alpha p 0.001”) required 52 h (with a Pentium III PC)
to obtain the results summarized in table 6.
Note that the full table of test statistics for all marker
combinations and all permutation replicates consists of
entries, which would require 24 gigabytes of863 # 10
memory. The algorithm of Ge et al. (2003) reduces this
requirement to 380 megabytes by storing only test sta-
tistics for the permutation replicates of a single marker
combination at a time. The disadvantage of their ap-
proach for this example is related to running time. Ge
et al. (2003) discussed two ways to guarantee that the
same ordered set of permutation replicates is used for
each marker combination. The ﬁrst way is to reset the
random number generator at the same ﬁxed value for
each hypothesis. Since the dysbindin combined sample
consists of 203 families and each permutation replicate
requires permutation of transmitted/nontransmitted
haplotypes in each family, calls of the ran-8203 # 10
dom number generator are necessary for generating
permutation replicates. The time required for these810
calls is ∼1.5 h with our hardware. In the case that these
calls have to be repeated for each marker combination,
the additional running time is . The62 # 1.5 h p 93 h
second way discussed by Ge et al. (2003) is to recode
and store each permutation. However, 203 bits (∼26
bytes) of storage are required to store a single permu-
tation, resulting in a requirement of 2.4 gigabytes to
store all permutations. In addition, we expect that810
the coding and recoding of permutations would sub-
stantially increase the running time.
The results presented in table 6 for the dysbindin data
suggest an advantage of haplotype analysis as compared
with single-marker analysis, even after correction for
the increased number of tests, since the global P value
for “maxmarker p 1” is higher by a factor 16 than the
global P value obtained by consideration of all marker
combinations (i.e., “maxmarker p 6”). Also, in accor-
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Table 6
P Values Based on Permutation Replicates for the810
Dysbindin Combined-Family Sample (without Israeli
Families)
MAXMARKER
NO. OF
COMBINATIONS
P
Bonferronia Global
1 6 .000324 .000212
2 21 .000044 .000023
3 41 .000086 .000030
4 56 .000118 .000032
5 62 .000130 .000033
6 63 .000132 .000033
a Bonferroni-corrected smallest raw P value.
dance with the results of our simulation study, it can
be seen from table 6 that the global P value does not
increase much when too many marker combinations are
tested. Since the smallest raw P value corresponds to
, the option “maxmarker p 2” results in theB p {2,4}
smallest global P value. However, consideration of all
marker combinations increases the global P value by a
factor of only !1.5, although the number of single hy-
potheses increases by a factor of 3. Comparison of the
P value obtained by Bonferroni correction with the
global P value obtained by our method reveals that the
ratio of these values increases from ∼1.5 (for the set of
single marker combinations) up to 4 (for the set of all
marker combinations).
Discussion
We implemented a method that adequately accounts for
the multiple-testing problem that occurs in the context
of haplotype analysis. With the help of Ge et al.’s (2003)
idea to reduce a nested permutation algorithm to a single
permutation algorithm, computer running time is re-
duced drastically, and a power study becomes feasible.
Our implementation is optimized for the application to
haplotype analysis. Computer storage can be reduced by
consideration, for each marker combination, of only the
replicates with a raw P value a. With this feature, the
analysis of the dysbindin data could be performed with
the necessary number of permutation replicates. Fur-
thermore, we obtained a considerable gain in speed.
Since it was not necessary to proceed with one hypoth-
esis at a time, we did not have to do repeated calls
of the random number generator for each marker
combination.
In the simulation study, we have shown that our
method adequately accounts both for the LD of a set
of tightly linked markers and for the induced multiple-
testing problem. In contrast to Bonferroni correction of
the smallest P value, our method avoids being overly
conservative. Consistently, power increases substan-
tially when global P values are considered instead of
Bonferroni-corrected P values. Our method allows for
the simultaneous consideration of different marker
combinations and comprises, in particular, the analysis
of single markers. In this way, our method can be a step
toward a uniﬁed strategy to judge the signiﬁcance of
the association of a phenotype with a genomic region
as a whole. The need for this is highlighted by the
strongly increased true signiﬁcance levels for uncor-
rected P values shown in table 3.
However, some ﬂexibility remains with respect to the
set of marker combinations that will be considered.
With few markers, it is possible to consider all com-
binations, and our simulations show that, in general,
not much power is lost, even when the marker com-
bination with the strongest association does not consist
of all markers. On the other hand, we can hope to detect
high-order interactions or cis-acting effects if they are
present. For a densely spaced marker system of 20–50
markers, it is computationally impossible to consider
all combinations, even with our approach. In such a
situation, it is useful to consider only marker combi-
nations with 3 markers but also to allow combina-
tions of markers that are not neighbors. In this way, the
number of tests is restricted to a level that is compu-
tationally feasible, but all single-, two-, and three-locus
haplotype effects can be detected, including cis-acting
effects and haplotype effects that are blurred bymarkers
that arose in the region after the mutation event(s).
Our simulations for family data show that haplotype
analysis can be more powerful than single-locus analysis
when the background LD is taken into account ade-
quately, as by our method, and also after correction for
the multiple testing. Studies for case-control data under
a coalescent model with a simple Bonferroni correction
did not detect a gain in terms of power for haplotype
analysis (Kaplan and Morris 2001).
Of course, our simulation study covers only a limited
range of possible disease scenarios, but we do not think
that it favors haplotype analysis inadequately. On the
contrary, we modeled only a single disease haplotype,
but the beneﬁt of haplotype analysis versus single-locus
analysis is stronger with multiple disease alleles (Morris
and Kaplan 2002). Thus, on average, the power gain is
likely to be even stronger than the gain found in our
study. In addition, we modeled markers that were in
moderate LD, and we would expect our method to per-
form even better under strong LD, both in comparison
with single-marker analysis and in comparison with
Bonferroni-corrected P values.
Besides these issues, our simulation study suggests
that haplotype analysis is particularly favorable for nu-
clear families with multiple affected siblings. At least as
far as single-marker analysis is concerned, case-control
data has higher power than TDT analysis of trio data,
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under many disease scenarios, since the latter pays a
price for being robust against population stratiﬁcation.
However, we observed that nuclear families with two
affected children were much more powerful than trios.
Hence, a comparison of nuclear families with multiple
affected siblings and case-control data, on the basis of
an equal genotyping effort, would be highly interesting.
In general, nuclear families allow for very precise hap-
lotype reconstruction (Becker and Knapp 2002; Schaid
2002), such that the haplotypic information can be fully
exploited. Furthermore, as mentioned above, families
with multiple affected siblings are genetically more
loaded and therefore lead to an increased power (Risch
and Teng 1998; Fingerlin et al. 2004). Thus, the com-
parison can be reﬁned to a comparison with case-con-
trol data in which the cases are index cases from affected
siblings. We are currently working on an implementa-
tion for case-control data, which will yield the pos-
sibility to compare the performance of case-control and
nuclear-family data. (Note that, for case-control data
also, the underlying distribution is often unknown, since
asymptotic theory is difﬁcult to apply when the number
of different haplotypes is high.) Besides that, the idea
of Ge et al. (2003) is quite general and can be applied
to obtain global P values for different kinds of test sta-
tistics, including tests for speciﬁc genetic models and
models of interaction. For family data, the principle has
been implemented in the latest update of our program
FAMHAP (Becker and Knapp 2004).
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